Search - tctmd.com

Displaying 541 - 560 of 658

Sort: Relevancy | Date

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

Presentation TCT 2013

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Presenter: Michael Joner

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Presenter: Erwin Blessing

October 31, 2013

Presentation TCT 2013

Pushing the Envelope: BVS as a Workhorse Device (With Case Examples)

Presenter: Samer Mansour

October 30, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

Presentation TCT 2013

TCT-17. Current Perspectives On Stent Fractures: Trends, Characteristics And Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience...

Presenter: Al Fazir Omar

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

Critical Examination of Current Clinical Outcomes with Best-in-Class Contemporary Permanent Polymer Metallic DES: Can New Devices Improve upon These Results?

Presenter: Ran Kornowski

October 27, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

DESyneBD Novolimus-Eluting Coronary Stent: Device Design and Extended Clinical Study Follow-up

Presenter: Ricardo Costa

October 27, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

Advertisement

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Atherectomy and Drug-Coated Balloons: Device Selection, Technical Pitfalls and Available Data

Pushing the Envelope: BVS as a Workhorse Device (With Case Examples)

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

TCT-17. Current Perspectives On Stent Fractures: Trends, Characteristics And Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Critical Examination of Current Clinical Outcomes with Best-in-Class Contemporary Permanent Polymer Metallic DES: Can New Devices Improve upon These Results?

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

DESyneBD Novolimus-Eluting Coronary Stent: Device Design and Extended Clinical Study Follow-up

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content